Skip to content
Search AI Powered

Latest Stories

MURs have been decommissioned

Community pharmacy owners have reminded not to provide any more Medicines Use Review (MURs) as the service has now been decommissioned.

Contractors were able to provide a total of 100 MURs in 2020-21 ahead of the service being scrapped.


Any pending claim for MURs must be submitted by April 5 in accordance with the usual Drug Tariff claims process.

In an update, the Pharmaceutical Services Negotiating Committee (PSNC) has said contractors who have previously provided MURs will need to consider the following points as the service has now been decommissioned:

Practice leaflets will need to be updated to remove MURs from the list of services that the pharmacy provides; however, contractors are reminded that NHS England and NHS Improvement (NHSE&I) will not take action against contractors who have not updated these during the period of the pandemic.

Promotional materials for MURs such as leaflets, posters, service ladders should be removed from public view to prevent any confusion about the availability of this service. If contractors have their own website, any information about MURs should also be removed.

Updating the NHS website

PSNC has requested that MURs are removed centrally from the NHS website so contractors do not have to individually remove MURs from their NHS website profiles. The pharmacy negotiator is still waiting for confirmation on if this will occur.

However, contractors must ensure that they verify and where necessary, update the information contained in their NHS website profile at least once of the each quarter of the financial year.

The new quarter has started today (April 1), therefore contractors could consider updating and verifying their profiles and therefore they need to remove MURs from their pharmacy profile as part of this process in the coming days to meet this requirement.

Copies of records of MURs should be kept for at least two years after the date on which the MUR took place; this still applies even though the service has now been decommissioned.

Quarterly reporting of MUR data has not been required during the pandemic therefore there is no need to report the final quarter of data to NHSE&I as the service has been decommissioned.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less